These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 10642676

  • 1. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases.
    Tosti A, Piraccini BM, Lorenzi S.
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):217-24. PubMed ID: 10642676
    [Abstract] [Full Text] [Related]

  • 2. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK, Gregurek-Novak T, Konnikov N, Lynde CW, Hofstader S, Summerbell RC.
    J Cutan Med Surg; 2001 Feb; 5(3):206-10. PubMed ID: 11685666
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM, Sisti A, Tosti A.
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [Abstract] [Full Text] [Related]

  • 4. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK, Konnikov N, Lynde CW.
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [Abstract] [Full Text] [Related]

  • 5. Treatment of nondermatophyte mold and Candida onychomycosis.
    Tosti A, Piraccini BM, Lorenzi S, Iorizzo M.
    Dermatol Clin; 2003 Jul; 21(3):491-7, vii. PubMed ID: 12956201
    [Abstract] [Full Text] [Related]

  • 6. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A, Nathansohn N, Trau H, Amichai B, Grunwald MH.
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [Abstract] [Full Text] [Related]

  • 7. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
    Baudraz-Rosselet F, Ruffieux C, Lurati M, Bontems O, Monod M.
    Dermatology; 2010 Feb; 220(2):164-8. PubMed ID: 20110639
    [Abstract] [Full Text] [Related]

  • 8. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK, Lynde CW, Konnikov N.
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [Abstract] [Full Text] [Related]

  • 9. Uncommon clinical patterns of Fusarium nail infection: report of three cases.
    Baran R, Tosti A, Piraccini BM.
    Br J Dermatol; 1997 Mar; 136(3):424-7. PubMed ID: 9115931
    [Abstract] [Full Text] [Related]

  • 10. Nondermatophyte causes of onychomycosis and superficial mycoses.
    Gupta AK, Elewski BE.
    Curr Top Med Mycol; 1996 Dec; 7(1):87-97. PubMed ID: 9504061
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK, Gregurek-Novak T.
    Dermatology; 2001 Dec; 202(3):235-8. PubMed ID: 11385230
    [Abstract] [Full Text] [Related]

  • 12. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S, Nir N, Henri T.
    J Dermatolog Treat; 2005 Dec; 16(5-6):327-30. PubMed ID: 16428154
    [Abstract] [Full Text] [Related]

  • 13. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
    Grover C, Bansal S, Nanda S, Reddy BS, Kumar V.
    Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
    [Abstract] [Full Text] [Related]

  • 14. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
    Kaçar N, Ergin S, Ergin C, Erdogan BS, Kaleli I.
    Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
    [Abstract] [Full Text] [Related]

  • 15. Onychomycosis: Diagnosis and management.
    Singal A, Khanna D.
    Indian J Dermatol Venereol Leprol; 2011 Jan; 77(6):659-72. PubMed ID: 22016272
    [Abstract] [Full Text] [Related]

  • 16. Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B.
    Lurati M, Baudraz-Rosselet F, Vernez M, Spring P, Bontems O, Fratti M, Monod M.
    Dermatology; 2011 Jan; 223(4):289-92. PubMed ID: 22236569
    [Abstract] [Full Text] [Related]

  • 17. Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
    Ranawaka RR, de Silva N, Ragunathan RW.
    J Dermatolog Treat; 2008 Jan; 19(5):308-12. PubMed ID: 19160539
    [Abstract] [Full Text] [Related]

  • 18. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
    Tosti A, Piraccini BM, Stinchi C, Lorenzi S.
    Br J Dermatol; 1996 Nov; 135(5):799-802. PubMed ID: 8977686
    [Abstract] [Full Text] [Related]

  • 19. Other fungi causing onychomycosis.
    Moreno G, Arenas R.
    Clin Dermatol; 2010 Mar 04; 28(2):160-3. PubMed ID: 20347658
    [Abstract] [Full Text] [Related]

  • 20. [Therapy with ciclopirox lacquer of onychomycoses caused by molds].
    Ulbricht H, Wörz K.
    Mycoses; 1994 Mar 04; 37 Suppl 1():97-100. PubMed ID: 7854374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.